MRSN: Mersana Therapeutics, Inc. Common Stock Company Profile & Statistics

About

Mersana Therapeutics, Inc. is a biotechnology company. It focused on discovering and developing a pipeline of antibody drug conjugates. The company's product candidates include XMT-1522 and XMT-1536 which are in clinical stage. Mersana Therapeutics, Inc. is based in CAMBRIDGE, United States.

Info & Links

CEO

Martin Huber

Headquarters

840 MEMORIAL DRIVE
CAMBRIDGE, MA 02139, UNITED STATES

Auditor

Ernst & Young LLP

Share holders

Employees

123

Mersana Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

68.31M

Enterprise Value

14.90M

Enterprise Value/EBITDA(ttm)

-0.18

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

1.87

Price to Book(mrq)

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-214.20%

Profit Margin(ttm)

-385.28%

Return on Equity(ttm)

-401.37%

Return on Invested Capital(ttm)

-244.38%

Return on Assets(ttm)

-38.61%

Income Statement

Revenue(ttm)

34.84M

Revenue Per Share(ttm)

0.28

Gross Profit(ttm)

34.84M

EBITDA(ttm)³

-81.94M

Net Income Available to Common(ttm)

-74.62M

Diluted EPS(ttm)

-0.61

Share Statistics

Beta (5Y Monthly)

1.39

52-Week Change

-85.33%

S&P 500 52-Week Change

18.02%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

123.53M

Dividend Yield

0.00%

Float⁴

108.96M

% Held by Insiders

11.80%

% Held by Institutions

93.92%

Balance Sheet

Total Cash(mrq)

155.17M

Total Cash Per Share(mrq)

1.26

Total Debt(mrq)

25.46M

Total Debt/Equity(mrq)

2426.79%

Current Ratio(mrq)

2.35%

Quick Ratio(mrq)

2.35%

Book Value Per Share(mrq)

0.01

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.51

Free Cash Flow(ytd)

-63.22M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

MRSN

Mersana Therapeutics, Inc. Common Stock

Mersana Therapeutics, Inc. Common Stock Profile